HTX 0.00% 0.1¢ healthlinx limited

serious rerating ahead, page-32

  1. 1,196 Posts.
    If this is to be as I understand and expect, the most accurate indicator for cervical cancer currently released into the EU and other pending world wide markets?

    I ask you what responsible specialist,surgeon or patient would not demand this simple initial test prior to any other unnecessary intrusive examinations and/or prevent possible mis- diagnosis of symptoms?

    This doesn't even account for those patients who just want to keep up regular checks up due to possible predisposition through family history of cervical cancer. IMO simple Demand vs Supply.

 
watchlist Created with Sketch. Add HTX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.